|
Overview
|
Changes in gene expression underlie many biological phenomena. Real-time quantitative PCR is a highly sensitive method that utilizes small sample sizes and short experimental time frames. qPCR is especially useful for evaluating "RNA fingerprints" obtained from microarray or siRNA experiments. These gene expression technologies generate vast amounts of data. Yet there are often limited resources for subsequent independent validation studies. Cost, time, reagents, kit selection, and instrumentation considerations are crucial. Researchers, using microarrays or RNAi for mapping cellular pathways, prioritizing suitable targets for pharmaceutical intervention or diagnostics, determining toxicology or prognostics (disease progression), will find this meeting useful for developing qPCR as their validation tool of choice. |
• Pre-Conference Short Course Tutorial
• Technology Spotlights
• Interactive Focused Group Discussions
• MAQC Project Panel Discussion
• Molecular & Diagnostics Core Managers Roundtable
• Closing Panel of Experts
• Networking Opportunities with the Industry's Top Leaders
• Present a Poster and save $50
Dr. Stephen A. Bustin, University of London
Dr. Dirk Loeffert, QIAGEN GmbH
Dr. Raymond R. Samaha, Applied Biosystems
Dr. Gregory L. Shipley, UTHSC-Houston
Dr. James C. Willey, Medical College of Ohio
"This conference was an excellent resource for those new to qPCR as well as for those who have extensive experience in the technology. There was something new to learn for everyone."
D. Patel, Alpha Vax
"I came for 3 reasons- to learn more about the technique, to hear what the industry leaders are doing and to capture user feedback and/or concerns. I left with valuable information in all areas."
C. Ogream, Ambion
|
